Subacute cutaneous lupus erythematosus associated with radioiodine treatment.Clin Exp Dermatol. 2012 Oct; 37(7):753-4.CE
Abstract
Subacute cutaneous lupus erythematosus (SCLE) is characterized by nonscarring, photodistributed, annular or papulosquamous plaques with antibodies to Ro/SS-A antigen. We report a case of SCLE associated with radioiodine treatment.
Links
MeSH
Pub Type(s)
Case Reports
Journal Article
Language
eng
PubMed ID
22369225
Citation
Abbott, R A., et al. "Subacute Cutaneous Lupus Erythematosus Associated With Radioiodine Treatment." Clinical and Experimental Dermatology, vol. 37, no. 7, 2012, pp. 753-4.
Abbott RA, May K, Motley RJ. Subacute cutaneous lupus erythematosus associated with radioiodine treatment. Clin Exp Dermatol. 2012;37(7):753-4.
Abbott, R. A., May, K., & Motley, R. J. (2012). Subacute cutaneous lupus erythematosus associated with radioiodine treatment. Clinical and Experimental Dermatology, 37(7), 753-4. https://doi.org/10.1111/j.1365-2230.2011.04319.x
Abbott RA, May K, Motley RJ. Subacute Cutaneous Lupus Erythematosus Associated With Radioiodine Treatment. Clin Exp Dermatol. 2012;37(7):753-4. PubMed PMID: 22369225.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Subacute cutaneous lupus erythematosus associated with radioiodine treatment.
AU - Abbott,R A,
AU - May,K,
AU - Motley,R J,
Y1 - 2012/02/27/
PY - 2012/2/29/entrez
PY - 2012/3/1/pubmed
PY - 2013/4/13/medline
SP - 753
EP - 4
JF - Clinical and experimental dermatology
JO - Clin Exp Dermatol
VL - 37
IS - 7
N2 - Subacute cutaneous lupus erythematosus (SCLE) is characterized by nonscarring, photodistributed, annular or papulosquamous plaques with antibodies to Ro/SS-A antigen. We report a case of SCLE associated with radioiodine treatment.
SN - 1365-2230
UR - https://www.unboundmedicine.com/medline/citation/22369225/Subacute_cutaneous_lupus_erythematosus_associated_with_radioiodine_treatment_
L2 - https://doi.org/10.1111/j.1365-2230.2011.04319.x
DB - PRIME
DP - Unbound Medicine
ER -